{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:16:06Z","timestamp":1793920566637,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00259-016-3518-y","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T14:25:40Z","timestamp":1473690340000},"page":"589-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["18F-FDG PET\/CT in gastric MALT lymphoma: a bicentric experience"],"prefix":"10.1007","volume":"44","author":[{"given":"Domenico","family":"Albano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Fallanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Gianolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Giubbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"3518_CR1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","volume":"50","author":"P Isaacson","year":"1983","unstructured":"Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983;50:1410\u20136.","journal-title":"Cancer"},{"key":"3518_CR2","volume-title":"Tumours of haematopoietic and lymphoid tissues: world health organization classification of tumours, pathology, and genetics","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardinam JW. Tumours of haematopoietic and lymphoid tissues: world health organization classification of tumours, pathology, and genetics. Lyon: IARC Press; 2001."},{"key":"3518_CR3","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma","year":"1997","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The non-Hodgkin\u2019s lymphoma classification project. Blood. 1997;89:3909\u201318.","journal-title":"Blood"},{"key":"3518_CR4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/annonc\/mds643","volume":"24","author":"M Dreyling","year":"2013","unstructured":"Dreyling M, Thieblemont C, Gallamini A, et al. ESMO consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol. 2013;24:857\u201377.","journal-title":"Ann Oncol"},{"key":"3518_CR5","doi-asserted-by":"crossref","unstructured":"Taal BG, Burgers JM, van Heerde P, Hart AA, Somers R. The clinical spectrum and treatment of primary non-Hodgkin\u2019s lymphoma of the stomach. Ann Oncol. 1993;4:839\u201346.","DOI":"10.1093\/oxfordjournals.annonc.a058390"},{"key":"3518_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/modpathol.3880035","volume":"13","author":"NL Harris","year":"2000","unstructured":"Harris NL, Jaffe ES, Diebold J, et al. The world health organization classification of hematological malignancies report of the clinical advisory committee meeting, Arlie house Virginia, November 1997. Mod Pathol. 2000;13:193\u2013207.","journal-title":"Mod Pathol"},{"key":"3518_CR7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1080\/10428190500178399","volume":"46","author":"S Woehrer","year":"2005","unstructured":"Woehrer S, Strubel B, Chott A, Hoffmann M, Raderer M. Transmortation of MALT lymphoma to pure plasma cells histology following treatment with the anti-CD20 antibody rituximab. Leuk Lymphoma. 2005;46:1645\u20139.","journal-title":"Leuk Lymphoma"},{"key":"3518_CR8","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol"},{"key":"3518_CR9","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32:3048\u201358.","journal-title":"J Clin Oncol"},{"key":"3518_CR10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.semradonc.2007.02.005","volume":"17","author":"L Specht","year":"2007","unstructured":"Specht L. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Semin Radiat Oncol. 2007;17:190\u20137.","journal-title":"Semin Radiat Oncol"},{"key":"3518_CR11","first-page":"5","volume":"4","author":"BD Cheson","year":"2015","unstructured":"Cheson BD. Staging and response assessment in lymphomas: the new Lugano classification. Chin Clin Oncol. 2015;4:5.","journal-title":"Chin Clin Oncol"},{"key":"3518_CR12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.semnuclmed.2015.03.006","volume":"45","author":"NF Schwenzer","year":"2015","unstructured":"Schwenzer NF, Pfannenberg AC. PET\/CT, MR, and PET\/MR in lymphoma and melanoma. Semin Nucl Med. 2015;45:322\u201331.","journal-title":"Semin Nucl Med"},{"key":"3518_CR13","doi-asserted-by":"crossref","unstructured":"Zucca E, Copie-Bergman C, Ricardi U, Thieblemont C, Raderer M, Ladetto M. Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi144\u20138.","DOI":"10.1093\/annonc\/mdt343"},{"key":"3518_CR14","unstructured":"National Comprehensive Cancer Network guidelines on non-Hodgkin\u2019s lymphomas, version 2. 2014. Available at http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nhl.pdf ."},{"key":"3518_CR15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3322\/caac.21330","volume":"66","author":"M Raderer","year":"2016","unstructured":"Raderer M, Kiesewetter B, Ferreri AJ. Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin. 2016;66:152\u201371.","journal-title":"CA Cancer J Clin"},{"key":"3518_CR16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.2152","volume":"33","author":"G Treglia","year":"2015","unstructured":"Treglia G, Zucca E, Sadeghi R, Cavalli F, Giovanella L, Ceriani L. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis. Hematol Oncol. 2015;33:113\u201324.","journal-title":"Hematol Oncol"},{"key":"3518_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-016-0800-1","author":"D Albano","year":"2016","unstructured":"Albano D, Giubbini R, Bertagna F. 18F-FDG PET\/CT and primary hepatic MALT: a case series. Abdom Radiol (NY). 2016. doi: 10.1007\/s00261-016-0800-1 .","journal-title":"Abdom Radiol (NY)"},{"key":"3518_CR18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1023\/A:1008312726163","volume":"10","author":"M Hoffmann","year":"1999","unstructured":"Hoffmann M, Kletter K, Diemling M, et al. Positron emission tomography with fluorine-18\u20132-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol. 1999;10:1185\u20139.","journal-title":"Ann Oncol"},{"key":"3518_CR19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000070290","volume":"64","author":"M Hoffmann","year":"2003","unstructured":"Hoffmann M, Kletter K, Becherer A, Jager U, Chott A, Raderer M. 18FFluorodeoxyglucose positron emission tomography (18F-FDGPET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology. 2003;64:336\u201340.","journal-title":"Oncology"},{"key":"3518_CR20","first-page":"37","volume":"9","author":"V Ambrosini","year":"2006","unstructured":"Ambrosini V, Rubello D, Castellucci P, et al. Diagnostic role of 18F-FDG PET in gastric MALT lymphoma. Nucl Med Rev Cent East Eur. 2006;9:37\u201340.","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"3518_CR21","volume":"7","author":"L Fu","year":"2012","unstructured":"Fu L, Li H, Wang H, Xu B, Fan Y, Tian J. SUVmax\/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphoma. PLoS One. 2012;7, e50914.","journal-title":"PLoS One"},{"key":"3518_CR22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/RLU.0b013e3182393580","volume":"37","author":"Y Hirose","year":"2012","unstructured":"Hirose Y, Kaida H, Ishibashi M, et al. Comparison between endoscopic macroscopic classification and F-18 FDG PET findings in gastric mucosa-associated lymphoid tissue lymphoma patients. Clin Nucl Med. 2012;37:152\u20137.","journal-title":"Clin Nucl Med"},{"key":"3518_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/hon.905","volume":"28","author":"JH Yi","year":"2010","unstructured":"Yi JH, Kim SJ, Choi JY, Ko YH, Kim BT, Kim WS. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma. Hematol Oncol. 2010;28:57\u201361.","journal-title":"Hematol Oncol"},{"key":"3518_CR24","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00259-008-0771-8","volume":"35","author":"L Radan","year":"2008","unstructured":"Radan L, Fischer D, Bar-Shalom R, et al. FDG avidity and PET\/CT patterns in primary gastric lymphoma. Eur J Nucl Med Mol Imaging. 2008;35:1424\u201330.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3518_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0609.2007.00895.x","volume":"79","author":"C Perry","year":"2007","unstructured":"Perry C, Herishanu Y, Metzer U, et al. Diagnostic accuracy of PET\/CT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol. 2007;79:205\u20139.","journal-title":"Eur J Haematol"},{"key":"3518_CR26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdi093","volume":"16","author":"KP Beal","year":"2005","unstructured":"Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol. 2005;16:473\u201380.","journal-title":"Ann Oncol"},{"key":"3518_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2967\/jnumed.109.067892","volume":"51","author":"M Weiler-Sagie","year":"2010","unstructured":"Weiler-Sagie M, Bushelev O, Epelbaum R, et al. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med. 2010;51:25\u201330.","journal-title":"J Nucl Med"},{"key":"3518_CR28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12149-007-0125-9","volume":"22","author":"K Enomoto","year":"2008","unstructured":"Enomoto K, Hamada K, Inohara H, et al. Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings. Ann Nucl Med. 2008;22:261\u20137.","journal-title":"Ann Nucl Med"},{"key":"3518_CR29","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1080\/10428190600733499","volume":"47","author":"L Alinari","year":"2006","unstructured":"Alinari L, Castellucci P, Elstrom R, et al. 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma. 2006;47:2096\u2013101.","journal-title":"Leuk Lymphoma"},{"key":"3518_CR30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/annonc\/mdl295","volume":"17","author":"M Hoffmann","year":"2006","unstructured":"Hoffmann M, W\u00f6hrer S, Becherer A, et al. 18F-Fluoro-deoxyglucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. Ann Oncol. 2006;17:1761\u20135.","journal-title":"Ann Oncol"},{"key":"3518_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cncr.21967","volume":"107","author":"M Karam","year":"2006","unstructured":"Karam M, Novak L, Cyriac J, Ali A, Nazeer T, Nugent F. Role of fluorine-18 fluorodeoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer. 2006;107:175\u201383.","journal-title":"Cancer"},{"key":"3518_CR32","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","volume":"21","author":"RW Tsang","year":"2003","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21:4157\u201364.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3518_CR33","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/10428194.2012.717694","volume":"54","author":"P Sharma","year":"2013","unstructured":"Sharma P, Suman S, Singh H, et al. Primary gastric lymphoma: utility of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for detecting relapse after treatment. Leuk Lymphoma. 2013;54(5):951\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"3518_CR34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hon.2181","volume":"33","author":"E Carrillo-Cruz","year":"2015","unstructured":"Carrillo-Cruz E, Marin-Oyaga V, de la Cruz Vicente F, et al. Role of 18F-FDG-PET\/CT in the management of marginal zone B cell lymphoma. Hematol Oncol. 2015;33(4):151\u20138.","journal-title":"Hematol Oncol"},{"key":"3518_CR35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4166\/kjg.2016.67.4.183","volume":"67","author":"JW Hwang","year":"2016","unstructured":"Hwang JW, Jee SR, Lee SH, Kim JH, Seol SY, Lee SM. Efficacy of positron emission tomography\/computed tomography in gastric mucosa-associated lymphoid tissue lymphoma. Korean J Gastroenterol. 2016;67:183\u20138.","journal-title":"Korean J Gastroenterol"},{"issue":"12","key":"3518_CR36","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.3109\/10428194.2015.1030640","volume":"56","author":"SH Park","year":"2015","unstructured":"Park SH, Lee JJ, Kim HO, et al. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography\/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement. Leuk Lymphoma. 2015;56(12):3288\u201394.","journal-title":"Leuk Lymphoma"},{"key":"3518_CR37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdl468","volume":"18","author":"HK Tsai","year":"2007","unstructured":"Tsai HK, Li S, Ng AK, Silver B, Stevenson MA, Mauch PM. Role of radiation therapy in the treatment of stage I\/II mucosa-associated lymphiod tissue lymphoma. Ann Oncol. 2007;18:672\u20138.","journal-title":"Ann Oncol"},{"key":"3518_CR38","first-page":"867","volume":"138","author":"J Gerdes","year":"1991","unstructured":"Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 1991;138:867\u201373.","journal-title":"Am J Pathol"},{"key":"3518_CR39","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1007\/s00330-015-3734-z","volume":"25","author":"HR Koo","year":"2015","unstructured":"Koo HR, Parl JS, Kang KW, Han W, Park IA, Moon WK. Correlation between (18)F-FDG uptake on PET\/CT and prognostic factors in triple-negative breast cancer. Eur Radiol. 2015;25:3314\u201321.","journal-title":"Eur Radiol"},{"key":"3518_CR40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s13139-015-0363-z","volume":"50","author":"S Park","year":"2016","unstructured":"Park S, Lee E, Rhee S, et al. Correlation between semi-quantitative 18F-FDG PET\/CT parameters and Ki-67 expression in small cell lung cancer. Nucl Med Mol Imaging. 2016;50:24\u201330.","journal-title":"Nucl Med Mol Imaging"},{"key":"3518_CR41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1097-0142(19951015)76:8<1313::AID-CNCR2820760804>3.0.CO;2-1","volume":"76","author":"S Nakamura","year":"1995","unstructured":"Nakamura S, Akazawa K, Yao T, Tsuneyoshi M. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer. 1995;76:1313\u201324.","journal-title":"Cancer"},{"key":"3518_CR42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12185-012-1225-4","volume":"97","author":"Y Watanabe","year":"2013","unstructured":"Watanabe Y, Suefuji H, Hirose Y, et al. 18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential. Int J Hematol. 2013;97:43\u20139.","journal-title":"Int J Hematol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3518-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T09:34:52Z","timestamp":1718789692000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3518-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3518"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3518-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]}}}